Please assess the completion status of the following clinical trial:

Trial Title: The Tilburg Vasospasm Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* spontaneous subarachnoid hemorrhage (SAH) with aneurysmal pattern graded as a Fisher grade III or higher on cerebral CT-scan.~* CSF drainage by external lumbar catheter can start within 96 hours after the initial SAH~* the drainage can start prior to the treatment of the ruptured aneurysm~* informed consent is signed by the patient or his representative~Exclusion Criteria:~* spontaneous SAH with aneurysmal pattern graded as a Fisher grade I or II on CT and perimesencephalic hemorrhages~* traumatic SAH~* symptomatic hydrocephalus on admission necessitating drainage (EVD or ELD)~* the presence of a large intraventricular bloodclot in the third or fourth ventricle on CT~* the presence of a mass lesion with significant cerebral midline shift~* all patients whose neurological condition is too poor to allow clinical recognition of signs and symptoms of cerebral vasospasm. This includes all patients with a Hunt and Hess Grade V who failed to improve after initial resuscitation~* no informed consent~* mycotic aneurysms

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- external lumbar drainage (Type: ACTIVE_COMPARATOR): Within 96 hours of initial subarachnoid hemorrhage, patients were randomized for external lumbar drainage (ELD)of cerebrospinal fluid during a maximum of 7 days or standard treatment of subarachnoid hemorrhage without ELD
- No intervention (Type: NO_INTERVENTION): In this arm the patients received standard treatment following protocol for patients with subarachnoid hemorrhage

Based on this trial design, predict the completion outcome and termination type (if applicable).